ORAL VERSUS IM ADMINISTRATION OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER

被引：0
|
作者：
BEEX, L
BURGHOUTS, J
VANTURNHOUT, J
BREED, W
HILLEN, H
HOLDRINET, A
BOETIUS, G
HOOGENDOORN, G
DOESBURG, W
VERHULST, M
MEULENBERG, P
机构：
[1] ST RADBOUD HOSP, DEPT EXPTL & CHEM ENDOCRINOL, 6525 GA NIJMEGEN, NETHERLANDS
[2] CATHOLIC UNIV NIJMEGEN, DEPT STAT CONSULTAT, NIJMEGEN, NETHERLANDS
[3] GROOT ZIEKENGASTHUIS, DEPT MED, SHERTOGENBOSCH, NETHERLANDS
[4] ST CANISIUS WILHELMINA HOSP, NIJMEGEN, NETHERLANDS
[5] ST CATHARINA HOSP, EINDHOVEN, NETHERLANDS
[6] ST IGNATIUS HOSP, BREDA, NETHERLANDS
[7] DIACONESSEN HOSP, BREDA, NETHERLANDS
[8] ST GEERTRUIDEN HOSP, DEVENTER, NETHERLANDS
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1151 / 1156
页数：6
相关论文
共 50 条
  • [41] HORMONE THERAPY IN ADVANCED BREAST-CANCER - COMPARISON BETWEEN HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MAP) AND TAMOXIFEN (TMX)
    PANNUTI, F
    MARTONI, A
    FRUET, F
    CRICCA, A
    CANCER TREATMENT REPORTS, 1979, 63 (07): : 1219 - 1219
  • [42] CLINICAL-TRIAL OF HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN THE TREATMENT OF METASTATIC BREAST-CANCER AND REVIEW OF THE LITERATURE
    DAVILA, E
    VOGEL, CL
    EAST, D
    CAIRNS, V
    HILSENBECK, S
    CANCER, 1988, 61 (11) : 2161 - 2167
  • [43] CYCLICAL USE OF TAMOXIFEN AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER
    GUNDERSEN, S
    KVINNSLAND, S
    LUNDGREN, S
    KLEPP, O
    LUND, E
    BORMER, O
    HOST, H
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 17 (01) : 45 - 50
  • [44] PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR THE TREATMENT OF METASTATIC BREAST-CANCER WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE
    BLOSSEY, HC
    WANDER, HE
    KOEBBERLING, J
    NAGEL, GA
    CANCER, 1984, 54 (06) : 1208 - 1215
  • [45] ORAL HIGH-DOSE PROGESTINS AS TREATMENT FOR ADVANCED BREAST-CANCER
    LUNDGREN, S
    KVINNSLAND, S
    UTAAKER, E
    ACTA ONCOLOGICA, 1989, 28 (06) : 811 - 816
  • [46] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED OVARIAN-CANCER
    QUINN, MA
    ROME, RM
    GRANT, P
    PLANNER, RS
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (05) : 239 - 241
  • [47] HIGH-DOSE MEGESTROL-ACETATE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    TCHEKMEDYIAN, NS
    TAIT, N
    ABRAMS, J
    AISNER, J
    SEMINARS IN ONCOLOGY, 1988, 15 (02) : 44 - 49
  • [48] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED RENAL ADENOCARCINOMA
    DOBERAUER, C
    BECHER, R
    KURSCHEL, E
    ANDERS, C
    KLOKE, O
    BLUT, 1987, 55 (04): : 278 - 278
  • [49] PHARMACOKINETICS AND METABOLISM OF MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED BREAST-CANCER
    UTAAKER, E
    LUNDGREN, S
    KVINNSLAND, S
    AAKVAAG, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 31 (4A): : 437 - 441
  • [50] PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER PATIENTS
    ETIENNE, MC
    MILANO, G
    FRENAY, M
    RENEE, N
    FRANCOIS, E
    THYSS, A
    SCHNEIDER, M
    NAMER, M
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) : 1176 - 1182
12345